A CDMO can work in one stage or several. Which stages each of India’s listed CDMOs works on is the next level of this ladder.
| CMO | Manufacturing only. The older, thinner model. |
| CRO | Research for a fee — from lab chemistry to running clinical trials — with no factory. The R in CRDMO. |
| CRDMO | Research added at the front. Syngene and Anthem call themselves this. |
| China +1 | Customers keeping a second supplier outside China. The reason India’s CDMOs are being watched. |
| CRO | CMO | CDMO | |
|---|---|---|---|
| Does | Research — lab chemistry to clinical trials | Makes a drug by a process it is handed | Works out the process, then makes the drug |
| Factory | No | Yes | Yes |
| Paid | Per project, for time and people | Per kilo or per batch | Development fees first, then per kilo |
| Customer ties | Project by project | Replaceable, though a move needs the regulator’s approval | Harder to replace — it developed the process, and its plant is named in the drug’s approval |
From ₹28,953 crore in FY21 to ₹47,502 crore in FY26 — 10% a year, compounded. Annual accounts of the companies on this site; only years all of them report.
A sector, read end to end, and the companies as they are published. Roughly monthly. Nothing else, and one click to stop.
Not advice. Definitions are ours; figures are the companies’ own, from their annual accounts.